May 17, 2017. In light of the overwhelming record evidence compiled by the FDA, there is no public health justification for the FDA to reconsider the deeming rule, or to postpone the implementation of its provisions.
Read More »On Health Policy
Coalition Letter Supporting Smoke-Free VA Facilities
May 11, 2017. We write in support of H.R. 1662, which would make facilities of the Veterans Health Administration (VHA) smoke-free.
Read More »NCHR Comments to EPA on Use of Lead Free Pipes
May 17, 2017. We strongly support the EPA’s efforts to establish labeling requirements and assure compliance with lead free standards for plumbing products intended for potable water systems. These regulations will help professionals, including manufacturers, distributors, and retailers, to more easily identify lead free materials and prevent the use of those that are not. Ultimately, this will reduce consumers’ exposure to lead in drinking water and help to prevent its serious, detrimental, and often irreparable health effects.
Read More »NCHR Comments to EPA on Methylene Choloride and N-Methylpyrrolidone Use in Paint Remover
The NCHR asks the EPA to stop the use of methylene chloride and NMP in paint removers because they can cause serious health problems, including death. They believe that warning labels aren’t enough and that banning these chemicals is the best way to keep people safe.
Read More »NCHR Remarks to the FDA Science Board on Increasing Patient Engagement
May 9, 2017. We strongly support FDA efforts to strengthen the role of patients and we urge the agency to define patients as those who use medical products, whether or not they are seriously ill.
Read More »